## **Core Concept**
Fluconazole and ketoconazole are both antifungal medications used to treat various fungal infections. The key difference lies in their pharmacokinetic profiles, side effect profiles, and drug interactions. Systemic mycoses require antifungal agents that are effective and have a favorable safety profile.

## **Why the Correct Answer is Right**
Fluconazole is preferred over ketoconazole for systemic mycoses primarily due to its better safety profile, particularly concerning hepatotoxicity. Ketoconazole is known to cause severe liver injury, and this risk is higher compared to fluconazole. Additionally, fluconazole has a broader spectrum of activity against certain systemic fungal infections, such as cryptococcal meningitis and candidiasis. Its pharmacokinetic properties, including better penetration into the cerebrospinal fluid, make it more suitable for treating certain systemic infections.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, reasons might include pharmacokinetics, efficacy, or cost, which are not detailed here.
- **Option B:** Similarly, this option is not provided but could relate to specific drug interactions or resistance profiles.
- **Option C:** Without specifics, it's hard to address, but it might relate to patient populations or specific infections.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that ketoconazole's use has significantly declined due to its potential for hepatotoxicity and its inhibition of the cytochrome P450 system, leading to dangerous drug interactions. Fluconazole, being a safer alternative with less potential for drug interactions and hepatotoxicity, is often the preferred choice for systemic mycoses.

## **Correct Answer:** .